Jci_page_head_homepage_01 Jci_page_head_homepage_02
Murray Korc
Published in Volume 119, Issue 11
J Clin Invest. 2009; 119(11):3208–3211 doi:10.1172/JCI41230
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Consequences of Smad4 haploinsufficiency.

As shown by Bornstein et al. in their study in this issue of the JCI (7), attenuated Smad4 levels in HNSCC lead to genomic instability, upregulation of phosphorylated R-Smad3 (R-Smad3-PP), excessive Ras activation (through overexpression or mutation), increased production of TGF-βs, and enhanced inflammation. In theory, oncogenic Ras can enhance Smad4 degradation (red line), and ligands such as EGF or HGF can activate the Ras/MAKP pathway to further modulate Smad4 function. The net result is altered transcriptional regulation of numerous genes leading to enhanced cancer spread and metastasis.